Determination of dextromethorphan and its metabolites in rat serum by liquid-liquid extraction and liquid chromatography with fluorescence detection.

[1]  S. Holtzman.  Discriminative stimulus effects of dextromethorphan in the rat , 1994, Psychopharmacology.

[2]  Kenneth R Wehmeyer,et al.  Semi-automated liquid--liquid back-extraction in a 96-well format to decrease sample preparation time for the determination of dextromethorphan and dextrorphan in human plasma. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  S. Hoke,et al.  Rapid bioanalytical determination of dextromethorphan in canine plasma by dilute-and-shoot preparation combined with one minute per sample LC-MS/MS analysis to optimize formulations for drug delivery. , 2000, Journal of pharmaceutical and biomedical analysis.

[4]  R. Mcfee,et al.  Dextromethorphan: another "ecstasy"? , 2000, Archives of family medicine.

[5]  L. Price,et al.  Dextromethorphan-induced psychosis. , 2000, The American journal of psychiatry.

[6]  K. Nicholson,et al.  Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys , 1999, Psychopharmacology.

[7]  R. Tyndale,et al.  Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[8]  R. Yoast,et al.  Abuse of dextromethorphan. , 1999, Archives of family medicine.

[9]  H. T. Kristensen.  Simultaneous determination of dextromethorphan and its metabolites in human plasma by capillary electrophoresis. , 1998, Journal of pharmaceutical and biomedical analysis.

[10]  K. Wehmeyer,et al.  Determination of dextromethorphan and dextrorphan in human plasma by liquid chromatography/tandem mass spectrometry. , 1997, Journal of mass spectrometry : JMS.

[11]  E. Sellers,et al.  Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat. , 1995, The Journal of pharmacology and experimental therapeutics.

[12]  T. F. Murray,et al.  High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel. , 1992, Molecular pharmacology.

[13]  A. Somogyi,et al.  Simultaneous Determination of Dextromethorphan and Three Metabolites in Plasma and Urine Using High‐Performance Liquid Chromatography with Application to Their Disposition in Man , 1990, Therapeutic drug monitoring.

[14]  D. Greenberg,et al.  Antagonist drug selectivity for radioligand binding sites on voltage-gated and N-methyl-d-aspartate receptor-gated Ca2+ channels , 1989, Neuroscience Letters.

[15]  Shih-Ling Chang,et al.  Simplified Phenotyping with Dextromethorphan by Thin‐Layer Chromatography: Application to Clinical Laboratory Screening for Deficiencies in Oxidative Drug Metabolism , 1988, Therapeutic drug monitoring.

[16]  M. Leid,et al.  Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes. , 1984, Life sciences.